RT Journal Article
SR Electronic
T1 Transmission of B.1.617.2 Delta Variant between vaccinated healthcare workers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.19.21266406
DO 10.1101/2021.11.19.21266406
A1 Steven A. Kemp
A1 Mark TK Cheng
A1 Will Hamilton
A1 Kimia Kamelian
A1 INSACOG Consortium
A1 Sujit Singh
A1 Partha Rakshit
A1 Anurag Aggrawal
A1 Chris Illingworth
A1 Ravindra K. Gupta
YR 2021
UL http://medrxiv.org/content/early/2021/11/21/2021.11.19.21266406.abstract
AB Breakthrough infections with SARS-CoV-2 Delta variant have been reported in vaccine recipients and in individuals infected with previous variants. However the potential for fully vaccinated individuals (two doses) to transmit SARS-CoV-2 is unclear. We here analyse data from health care workers in two hospitals in India, constructing probable transmission networks from epidemiological and virus genome sequence data using a suite of computational approaches. Among known cases we identify a high probability that doubly vaccinated individuals transmitted SARS-CoV-2, and potential cases of virus transmission between individuals who had received two doses of vaccine. Our findings highlight the need for ongoing infection control measures even in highly vaccinated populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementR.K.G. is supported by a Wellcome Trust Senior Fellowship in Clinical Science (WT108082AIA). This study was supported by the Cambridge NIHRB Biomedical Research Centre. S.A.K. is supported by the Bill and Melinda Gates Foundation via PANGEA grant OPP1175094.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study of vaccine elicited antibodies in sera from vaccinees was obtained from the East of England Cambridge Central Research Ethics Committee Cambridge (REC ref. 17/EE/0025). Use of convalescent sera had ethical approval from the South Central Berkshire B Research Ethics Committee (REC ref. 20/SC/0206; IRAS 283805). Studies involving HCWs (including testing and sequencing of respiratory samples) were reviewed and approved by The Institutional Human Ethics Committees of the National Centre for Disease Control (NCDC) and CSIR IGIB(NCDC/2020/NERC/14 and CSIRIGIB/IHEC/202021/01). Participants provided informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://github.com/TKMarkCheng/Indian_HCW